Modular Biomanufacturing Facilities: Cell and Gene Therapy Development

Source: G-CON Manufacturing
Modular Biomanufacturing Facilities: Cell and Gene Therapy Development

The alarming rate of cancer pervasiveness around the world has caused the spike in demand for gene therapy treatment.

According to Global Market Insights, the Cancer Gene Therapy Market size is expected to exceed $4.3 billion by 2024.

G-CON, recently announced the recent completion of a custom built cleanroom POD® system for Lonza, for their gene therapy manufacturing operation in Houston, TX.

G-CON’s Cell Therapy PODs® provide the most comprehensive, flexible and podular processing solutions for the personalized and regenerative healthcare industries. Our highly experienced team will work together with you to achieve the ideal cleanroom solution, which exceeds traditional infrastructures in technical advantages and value creation, making the legacy cost per sq. ft. analysis irrelevant.

Maik Jornitz, President and CEO of G-CON Manufacturing stated: “We committed to an aggressive timeframe for delivery and installation of the custom-built POD system because we knew of the importance of the timeline for Lonza in this cell therapy application, a major new area of drug development for Lonza as well as G-CON.”